Zobrazeno 1 - 10
of 152
pro vyhledávání: '"G. Landonio"'
Autor:
Elena Mazza, Emanuele Pignoli, Lorenza Gandola, Paolo Pedrazzoli, Salvatore Siena, Monica Terenziani, Franca Fossati-Bellani, G. Landonio, Filippo Spreafico, Geraldina Poggi, Graziella Cefalo, Maura Massimino
Publikováno v:
European Journal of Cancer. 41:1304-1310
We retrospectively studied 26 consecutive adults treated for medulloblastoma using paediatric protocols. Between 1987 and 2003, patients ⩾18 years old were given adjuvant chemotherapy consisting of one of two ‘paediatric’ regimens (depending on
Autor:
Giuliano Rizzardini, Umberto Tirelli, Adriana Ammassari, G. Landonio, Antonio Nicolato, A. Rocca, Emanuela Vaccher, Renato Maserati, Antonella Castagna, Adriano Lazzarin, Roberto Luzzati, Annalisa Ridolfo, Marco Fasan, G. Butti, Andrea Antinori, Massimo Scerrati
Publikováno v:
Neurology. 54:993-997
In this multicenter, retrospective study of 160 brain biopsies in the assessment of HIV-related focal brain lesions, diagnostic sensitivity was acceptable (87%), but the procedure carried considerable morbidity (7.5%) and mortality (3.1%). Moreover,
Autor:
F. Cavicchi, A. P. Iori, Vincenzo Minotti, Giampaolo Bucaneve, Giuseppe Gentile, Francesco Menichetti, G. Landonio, Pietro Martino, A. Del Favero, Alessandra Micozzi, G. Barbabietola
Publikováno v:
Supportive Care in Cancer. 7:134-139
Hospitalization and empirical broad-spectrum, intravenous antibiotics are the standard treatment for febrile cancer patients. Recent evidence supports the suggestion that febrile episodes in a low-risk population can be managed successfully in an out
Autor:
M. De Rosa, C. Besana, Francesco Boccardo, A. Lucenti, Giovanni Citterio, Enzo Galligioni, Roberto Sorio, Luciano Canobbio, G. Landonio, Enzo Maria Ruggeri, Francesco Cognetti, C. Baiocchi, F. Calabresi, Alessandra Rubagotti
Publikováno v:
Tumori Journal. 84:534-539
Background The purpose of the present study was to investigate the therapeutic effectiveness of interleukin-2 (IL-2) and interferon (IFN), either alone or in combination, in comparable groups of patients affected by advanced renal cell carcinoma (RCC
Autor:
Enrico Ghislandi, Ornella Gottardi, Claudia Baiocchi, Daniela Cattaneo, Massimo Ferrari, Margherita Majno, G. Landonio
Publikováno v:
Tumori Journal. 80:468-472
Background Metastatic renal cell carcinoma is a “capricious” tumor. Many prognostic factors have been evaluated, treatment is still controversial, and results are not coincident. Methods We reviewed 156 patients with metastatic renal cell carcino
Autor:
G. Landonio
Publikováno v:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 26
Autor:
Annamaria Nosari, Enrico Ghislandi, Silvia Cantoni, Pierluigi Oreste, Daniela Cattaneo, G. Landonio
Publikováno v:
Tumori Journal. 79:224-226
We report nasopharyngeal angiofibroma in a 13 year old boy treated with embolization, surgical excision and radiotherapy, which recurred 13 years later. No features of sarcomatous transformation were found, but the tumor had a locally aggressive cour
Autor:
M, Riva, G, Landonio, O, Arena, A, Citterio, C, Galli, E, Ferrante, A, Brioschi, M, Collice, M, Gambacorta, G, Scialfa, C A, Defanti, S, Siena
Publikováno v:
Forum (Genoa, Italy). 11(1)
Brain metastases (BrM) are tumours that originate in tissues outside the central nervous system and spread secondarily to involve mainly the brain. The management of patients with cerebral metastases is complex, costly, and in some instances controve
Publikováno v:
Forum (Genoa, Italy). 11(1)
The role of chemotherapy (CT) for brain metastases (BrM) is still controversial. Limited life expectancy and presence of the blood-brain barrier (BBB) have been considered as contraindications for relatively aggressive therapies, such as CT. Neverthe
Publikováno v:
Journal of neuro-oncology. 48(3)
The reduced bioavailability of chemotherapeutic agents is one of the reasons that explains the limited efficacy of adjuvant chemotherapy in high grade glioma patients. We report how even the results of high dose sequential chemotherapy can be influen